tiprankstipranks
Clinigence Holdings (NUTX)
NASDAQ:NUTX
US Market

Clinigence Holdings (NUTX) Technical Analysis

178 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Clinigence Holdings’s (NUTX) Moving Averages Convergence Divergence (MACD) indicator is -0.46, suggesting Clinigence Holdings is a Buy.
Clinigence Holdings’s (NUTX) 20-Day exponential moving average is 5.36, while Clinigence Holdings’s (NUTX) share price is $5.72, making it a Sell.
Clinigence Holdings’s (NUTX) 50-Day exponential moving average is 6.67, while Clinigence Holdings’s (NUTX) share price is $5.72, making it a Sell.

Clinigence Holdings (NUTX) Pivot Points

Jul 17, 2024, 07:33 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.91
4.11
4.44
4.64
4.97
5.17
5.50
Fibonacci
4.11
4.31
4.44
4.64
4.84
4.97
5.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Clinigence Holdings (NUTX) Moving Averages

Jul 17, 2024, 07:33 AM
Period
Simple
Exponential
MA5
4.63Buy
4.84Buy
MA10
5.13Sell
5.02Buy
MA20
5.38Sell
5.36Sell
MA50
6.16Sell
6.67Sell
MA100
9.47Sell
10.50Sell
MA200
19.04Sell
20.20Sell
Clinigence Holdings’s (NUTX) 10-Day exponential moving average is 5.02, while Clinigence Holdings’s (NUTX) share price is $5.72, making it a Buy.
Clinigence Holdings’s (NUTX) 100-Day exponential moving average is 10.50, while Clinigence Holdings’s (NUTX) share price is $5.72, making it a Sell.
Clinigence Holdings’s (NUTX) stock price is $5.72 and Clinigence Holdings’s (NUTX) 50-day simple moving average is 6.16, creating a Sell signal.
Clinigence Holdings’s (NUTX) stock price is $5.72 and Clinigence Holdings’s (NUTX) 100-day simple moving average is 9.47, creating a Sell signal.
Clinigence Holdings’s (NUTX) stock price is $5.72 and Clinigence Holdings’s (NUTX) 200-day simple moving average is 19.04, creating a Sell signal.

Clinigence Holdings (NUTX) Technical Indicators

Jul 17, 2024, 07:33 AM
Name
Value
Implied Action
RSI (14)
41.76
Neutral
STOCH (9,6)
24.98
Neutral
STOCHRSI (14)
24.84
Neutral
MACD (12,26)
-0.46
Buy
ADX (14)
17.34
Buy
Williams %R
-60.31
Buy
CCI (14)
-63.28
Neutral
ATR (14)
0.57
-
Ultimate Oscillator
38.00
Neutral
ROC
-9.82
Sell
Clinigence Holdings’s (NUTX) Relative Strength Index (RSI) is 41.76, creating a Neutral signal.
Clinigence Holdings’s (NUTX) Trend Strength Indicator (ADX) is 17.34, creating a Buy signal.
Clinigence Holdings’s (NUTX) Commodity Channel Index (CCI) is -63.28, creating a Neutral signal.
Clinigence Holdings’s (NUTX) Price Rate of Change (ROC) is -9.82, creating a Sell signal.

FAQ

Is NUTX a Buy, Hold, or Sell?
Based on NUTX’s technical indicators, NUTX is a Sell.
    What is NUTX’s RSI (14)?
    NUTX’s RSI (14) is 41.76, which suggests NUTX is a Neutral.
      What is NUTX’s MACD?
      NUTX’s MACD is -0.46, which suggests NUTX is a Buy.
        What is NUTX’s 5-day moving average?
        NUTX’s 5-day moving average is 4.63, which suggests NUTX is a Buy.
          What is NUTX’s 20-day moving average?
          NUTX 20-day moving average is 5.38, which suggests NUTX is a Sell.
            What is NUTX’s 50-day moving average?
            NUTX’s 50-day moving average is 6.16, which suggests NUTX is a Sell.
              What is NUTX’s 200-day moving average?
              NUTX’s 200-day moving average is 19.04, which suggests NUTX is a Sell.
                What is NUTX’s Williams % R (14)?
                NUTX’s Williams % R (14) is -60.31, which suggests NUTX is a Buy.
                  What is NUTX’s CCI (14)?
                  NUTX’s CCI (14) is -63.28, which suggests NUTX is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis